Literature DB >> 20549472

AKT signaling in physiology and disease.

Krishna M Vasudevan1, Levi A Garraway.   

Abstract

The serine/threonine kinase AKT functions as a critical mediator of signaling downstream of PI3 kinase. Studies over the last two decades have firmly established the importance of AKT in the regulation of cell survival, proliferation, and insulin-dependent metabolic cell responses. AKT executes these diverse tasks through phosphorylation of numerous cellular substrates. Substantial progress has been made in understanding the regulation of AKT activity by upstream kinases and elucidating downstream mechanisms that mediate its myriad cellular effects. Here, we present an overview of AKT regulation and function in physiological and pathological settings. An emphasis is placed on the involvement of aberrant AKT signaling in human diseases ranging from diabetes to cancer and neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549472     DOI: 10.1007/82_2010_66

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  53 in total

1.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

2.  Calorie restriction leads to greater Akt2 activity and glucose uptake by insulin-stimulated skeletal muscle from old rats.

Authors:  Haiyan Wang; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

Review 3.  FKBP51 regulation of AKT/protein kinase B phosphorylation.

Authors:  Liewei Wang
Journal:  Curr Opin Pharmacol       Date:  2011-04-15       Impact factor: 5.547

4.  Context-dependent antagonism between Akt inhibitors and topoisomerase poisons.

Authors:  Marina Gálvez-Peralta; Karen S Flatten; David A Loegering; Kevin L Peterson; Paula A Schneider; Charles Erlichman; Scott H Kaufmann
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

5.  Mitochondria associated membranes (MAMs) as critical hubs for apoptosis.

Authors:  Carlotta Giorgi; Mariusz R Wieckowski; Pier Paolo Pandolfi; Paolo Pinton
Journal:  Commun Integr Biol       Date:  2011-05

6.  Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.

Authors:  Gengyun Wen; Mei Hong; Bingyan Li; Wupeng Liao; Simon K Cheng; Burong Hu; Gloria M Calaf; Ping Lu; Michael A Partridge; Jian Tong; Tom K Hei
Journal:  Int J Oncol       Date:  2011-06-23       Impact factor: 5.650

7.  Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice.

Authors:  Yang Yu; Xiaojing Li; Julie Blanchard; Yi Li; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  J Neural Transm (Vienna)       Date:  2014-08-13       Impact factor: 3.575

8.  Suppressive effect of formononetin on platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells.

Authors:  Zhuo Chen; Suixin Liu; Ying Cai; Kangling Xie; Wenliang Zhang; Lei Dong; Yuan Liu; Fan Zheng; Yaoshan Dun; Ning Li
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

9.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse.

Authors:  To-Ha Thai; Heide Christine Patterson; Duc-Hung Pham; Katalin Kis-Toth; Denise A Kaminski; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

10.  Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones.

Authors:  Debasis Mondal; Kai Liu; Milton Hamblin; Joseph A Lasky; Krishna C Agrawal
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.